Skip to content
  • Home
  • Contact Us
  • About Us
  • Home
  • Contact Us
  • About Us
  • General
  • Business
  • Education
  • Government
  • Medical
  • Sports
  • French
  • Press Releases
    • PR-French
Menu
  • General
  • Business
  • Education
  • Government
  • Medical
  • Sports
  • French
  • Press Releases
    • PR-French
Search
  • General
  • Business
  • Education
  • Government
  • Medical
  • Sports
  • French
  • Press Releases
    • PR-French
Menu
  • General
  • Business
  • Education
  • Government
  • Medical
  • Sports
  • French
  • Press Releases
    • PR-French
Search
Day: September 13, 2024

AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies

September 13, 2024

AI-Media and Speechmatics Partnership AI-Media and Speechmatics today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market.

Read More

AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies

September 13, 2024

AI-Media and Speechmatics Partnership AI-Media and Speechmatics today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market.

Read More

AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies

September 13, 2024

AI-Media and Speechmatics Partnership AI-Media and Speechmatics today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market.

Read More

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

September 13, 2024

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in

Read More

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

September 13, 2024

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in

Read More

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

September 13, 2024

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in

Read More
Page1 Page2 Page3 Page4 Page5
RECENT POSTS

Kylian Mbappe Criticizes Viral Dictator Meme for Lack of Awareness

September 11, 2026

IMF Discusses Senegal’s Debt Restructuring and Economic Reforms

September 11, 2026

Children Die in a School Fire in Bukavu

September 11, 2026

Angolan National Agency for Petroleum, Gas and Biofuels (ANPG) Secures New Deepwater Deals at Angola Oil and Gas 2026

September 11, 2026

BRICS to Launch Own Cross-Border Payment System, BRICS Pay

September 11, 2026

New Ebola Treatment Centre Opens in Kisangani to Enhance Response Efforts

September 11, 2026

DR Congo’s Ebola Outbreak Shows Divergent Transmission Trends: WHO

September 9, 2026

Mahama Urges Ghana Football Association to Revitalize Youth Leagues

September 9, 2026
Copyright © 2026 Le Congo Tribune. All Rights Reserved.